In an attempt to restore the metabolic alterations that could be leading to death in T. gondii infection in the absence of CCR5-/-, mice were treated with Gemfibrozil, a PPARα agonist used in the treatment of dyslipidemia. This evidence concerns the gene PPARA and metabolic syndrome.